Clinical Trial Update: Phase II Randomized Trial of Ipilimumab Versus Ipilimumab and Radiotherapy in Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase II randomized trial comparing ipilimumab alone to ipilimumab with radiotherapy in metastatic melanoma was terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)

Snippet

Sponsor: NYU Langone Health | Conditions: Metastatic Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2018-02-23